Neonatal Alexander Disease: Novel GFAP Mutation and Comparison to Previously Published Cases

Neuropediatrics. 2018 Aug;49(4):256-261. doi: 10.1055/s-0038-1649500. Epub 2018 May 25.

Abstract

Alexander disease (AxD) is a genetic leukodystrophy caused by GFAP mutations leading to astrocyte dysfunction. Neonatal AxD is a rare phenotype with onset in the first month of life. The proband, belonging to a large pedigree with dominantly inherited benign familial neonatal epilepsy (BFNE), had a phenotype distinct from the rest of the family, with hypotonia and macrocephaly in addition to drug-resistant neonatal seizures. The patient deteriorated and passed away at 6 weeks of age. The pathological and neuroimaging data were consistent with the diagnosis of AxD. Genetic analysis of the proband identified a novel de novo GFAP missense mutation and a KCNQ2 splice site mutation segregating with the BFNE phenotype in the family. The GFAP mutation was located in the coil 2B region of GFAP protein, similar to most neonatal-onset AxD cases with an early death. The clinical and neuroradiological features of the previously published neonatal AxD patients are presented. This study further supports the classification of neonatal-onset AxD as a distinct phenotype based on the age of onset.

Publication types

  • Case Reports
  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alexander Disease / diagnostic imaging
  • Alexander Disease / genetics*
  • Alexander Disease / pathology
  • Brain / diagnostic imaging
  • Brain / pathology
  • Fatal Outcome
  • Glial Fibrillary Acidic Protein / genetics*
  • Humans
  • Infant
  • Male
  • Mutation*
  • Phenotype

Substances

  • GFAP protein, human
  • Glial Fibrillary Acidic Protein